Annual FCF
-$6.60 M
-$248.00 K-3.90%
December 1, 2023
Summary
- As of February 7, 2025, BRTX annual free cash flow is -$6.60 million, with the most recent change of -$248.00 thousand (-3.90%) on December 1, 2023.
- During the last 3 years, BRTX annual FCF has fallen by -$4.64 million (-236.06%).
- BRTX annual FCF is now -748.50% below its all-time high of -$778.00 thousand, reached on December 31, 2010.
Performance
BRTX Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$1.76 M
+$142.50 K+7.50%
September 1, 2024
Summary
- As of February 7, 2025, BRTX quarterly free cash flow is -$1.76 million, with the most recent change of +$142.50 thousand (+7.50%) on September 1, 2024.
- Over the past year, BRTX quarterly FCF has dropped by -$566.60 thousand (-47.56%).
- BRTX quarterly FCF is now -540.20% below its all-time high of -$274.60 thousand, reached on September 30, 2011.
Performance
BRTX Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$7.63 M
-$566.60 K-8.02%
September 1, 2024
Summary
- As of February 7, 2025, BRTX TTM free cash flow is -$7.63 million, with the most recent change of -$566.60 thousand (-8.02%) on September 1, 2024.
- Over the past year, BRTX TTM FCF has dropped by -$857.70 thousand (-12.66%).
- BRTX TTM FCF is now -791.02% below its all-time high of -$856.80 thousand, reached on March 31, 2011.
Performance
BRTX TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
BRTX Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -3.9% | -47.6% | -12.7% |
| 3 y3 years | -236.1% | -53.5% | -129.3% |
| 5 y5 years | -29.0% | -53.5% | -129.3% |
BRTX Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -96.4% | at low | -53.5% | +27.9% | -129.3% | at low |
| 5 y | 5-year | -236.1% | +5.1% | -318.2% | +27.9% | -288.7% | at low |
| alltime | all time | -748.5% | +5.1% | -540.2% | +27.9% | -791.0% | at low |
BioRestorative Therapies Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$1.76 M(-7.5%) | -$7.63 M(+8.0%) |
| Jun 2024 | - | -$1.90 M(-18.0%) | -$7.07 M(+9.1%) |
| Mar 2024 | - | -$2.32 M(+39.8%) | -$6.48 M(-1.8%) |
| Dec 2023 | -$6.60 M(+3.9%) | -$1.66 M(+39.2%) | -$6.60 M(-2.6%) |
| Sep 2023 | - | -$1.19 M(-9.2%) | -$6.78 M(-3.4%) |
| Jun 2023 | - | -$1.31 M(-46.2%) | -$7.01 M(-1.1%) |
| Mar 2023 | - | -$2.44 M(+33.1%) | -$7.09 M(+11.6%) |
| Dec 2022 | -$6.35 M(+89.1%) | -$1.83 M(+28.5%) | -$6.35 M(+12.1%) |
| Sep 2022 | - | -$1.43 M(+2.8%) | -$5.67 M(+16.4%) |
| Jun 2022 | - | -$1.39 M(-18.5%) | -$4.87 M(+15.3%) |
| Mar 2022 | - | -$1.70 M(+48.8%) | -$4.22 M(+26.7%) |
| Dec 2021 | -$3.36 M(+71.1%) | -$1.15 M(+81.9%) | -$3.33 M(+20.8%) |
| Sep 2021 | - | -$629.40 K(-15.2%) | -$2.76 M(+4.0%) |
| Jun 2021 | - | -$741.80 K(-8.8%) | -$2.65 M(+13.8%) |
| Mar 2021 | - | -$813.70 K(+42.2%) | -$2.33 M(+18.6%) |
| Dec 2020 | -$1.96 M(-71.8%) | -$572.10 K(+9.4%) | -$1.96 M(-38.7%) |
| Sep 2020 | - | -$523.10 K(+24.4%) | -$3.20 M(-27.2%) |
| Jun 2020 | - | -$420.40 K(-6.3%) | -$4.40 M(-18.9%) |
| Mar 2020 | - | -$448.60 K(-75.2%) | -$5.42 M(-22.0%) |
| Dec 2019 | -$6.95 M(+35.9%) | -$1.81 M(+5.5%) | -$6.95 M(+3.9%) |
| Sep 2019 | - | -$1.72 M(+18.7%) | -$6.70 M(+5.7%) |
| Jun 2019 | - | -$1.45 M(-27.0%) | -$6.33 M(+6.6%) |
| Mar 2019 | - | -$1.98 M(+27.5%) | -$5.94 M(+16.1%) |
| Dec 2018 | -$5.12 M(+32.7%) | -$1.55 M(+14.8%) | -$5.12 M(+3.9%) |
| Sep 2018 | - | -$1.35 M(+28.5%) | -$4.92 M(+20.7%) |
| Jun 2018 | - | -$1.05 M(-9.1%) | -$4.08 M(+7.6%) |
| Mar 2018 | - | -$1.16 M(-14.8%) | -$3.79 M(-1.6%) |
| Dec 2017 | -$3.86 M | -$1.36 M(+167.0%) | -$3.85 M(+8.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2017 | - | -$509.20 K(-33.5%) | -$3.56 M(-17.0%) |
| Jun 2017 | - | -$766.00 K(-37.2%) | -$4.29 M(-6.8%) |
| Mar 2017 | - | -$1.22 M(+14.1%) | -$4.60 M(-11.3%) |
| Dec 2016 | -$5.19 M(+44.0%) | -$1.07 M(-13.6%) | -$5.19 M(-0.6%) |
| Sep 2016 | - | -$1.24 M(+14.6%) | -$5.22 M(+9.3%) |
| Jun 2016 | - | -$1.08 M(-40.3%) | -$4.78 M(+4.6%) |
| Mar 2016 | - | -$1.81 M(+64.1%) | -$4.57 M(+26.8%) |
| Dec 2015 | -$3.61 M(+6.2%) | -$1.10 M(+39.1%) | -$3.61 M(+9.1%) |
| Sep 2015 | - | -$792.20 K(-8.9%) | -$3.30 M(-1.3%) |
| Jun 2015 | - | -$869.40 K(+3.3%) | -$3.35 M(-2.4%) |
| Mar 2015 | - | -$841.90 K(+5.1%) | -$3.43 M(+1.0%) |
| Dec 2014 | -$3.40 M(+26.6%) | -$801.10 K(-4.1%) | -$3.40 M(+1.1%) |
| Sep 2014 | - | -$835.20 K(-12.4%) | -$3.36 M(+13.5%) |
| Jun 2014 | - | -$953.20 K(+18.2%) | -$2.96 M(+9.3%) |
| Mar 2014 | - | -$806.70 K(+5.6%) | -$2.71 M(+1.3%) |
| Dec 2013 | -$2.68 M(-35.9%) | -$763.80 K(+75.8%) | -$2.67 M(-10.7%) |
| Sep 2013 | - | -$434.40 K(-38.2%) | -$2.99 M(-0.5%) |
| Jun 2013 | - | -$702.50 K(-9.0%) | -$3.01 M(-34.1%) |
| Mar 2013 | - | -$771.80 K(-28.7%) | -$4.56 M(+9.0%) |
| Dec 2012 | -$4.19 M(+48.0%) | -$1.08 M(+140.1%) | -$4.19 M(-0.8%) |
| Sep 2012 | - | -$450.90 K(-80.0%) | -$4.22 M(+4.4%) |
| Jun 2012 | - | -$2.26 M(+473.5%) | -$4.04 M(+70.9%) |
| Mar 2012 | - | -$393.90 K(-64.7%) | -$2.37 M(-16.4%) |
| Dec 2011 | -$2.83 M(+263.6%) | -$1.12 M(+306.2%) | -$2.83 M(+65.1%) |
| Sep 2011 | - | -$274.60 K(-52.8%) | -$1.71 M(+19.1%) |
| Jun 2011 | - | -$581.70 K(-32.1%) | -$1.44 M(+67.9%) |
| Mar 2011 | - | -$856.80 K | -$856.80 K |
| Dec 2010 | -$778.00 K | - | - |
FAQ
- What is BioRestorative Therapies annual free cash flow?
- What is the all time high annual FCF for BioRestorative Therapies?
- What is BioRestorative Therapies annual FCF year-on-year change?
- What is BioRestorative Therapies quarterly free cash flow?
- What is the all time high quarterly FCF for BioRestorative Therapies?
- What is BioRestorative Therapies quarterly FCF year-on-year change?
- What is BioRestorative Therapies TTM free cash flow?
- What is the all time high TTM FCF for BioRestorative Therapies?
- What is BioRestorative Therapies TTM FCF year-on-year change?
What is BioRestorative Therapies annual free cash flow?
The current annual FCF of BRTX is -$6.60 M
What is the all time high annual FCF for BioRestorative Therapies?
BioRestorative Therapies all-time high annual free cash flow is -$778.00 K
What is BioRestorative Therapies annual FCF year-on-year change?
Over the past year, BRTX annual free cash flow has changed by -$248.00 K (-3.90%)
What is BioRestorative Therapies quarterly free cash flow?
The current quarterly FCF of BRTX is -$1.76 M
What is the all time high quarterly FCF for BioRestorative Therapies?
BioRestorative Therapies all-time high quarterly free cash flow is -$274.60 K
What is BioRestorative Therapies quarterly FCF year-on-year change?
Over the past year, BRTX quarterly free cash flow has changed by -$566.60 K (-47.56%)
What is BioRestorative Therapies TTM free cash flow?
The current TTM FCF of BRTX is -$7.63 M
What is the all time high TTM FCF for BioRestorative Therapies?
BioRestorative Therapies all-time high TTM free cash flow is -$856.80 K
What is BioRestorative Therapies TTM FCF year-on-year change?
Over the past year, BRTX TTM free cash flow has changed by -$857.70 K (-12.66%)